INTS

Intensity TherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

RSI (14)

44.9

Neutral

MACD Hist

0.02

Bullish

ATR (14)

0.31

Available

Vol Z (20)

-0.49

Normal

RET 20D

-2.9%

Negative

Dist 52W High

-89.9%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-10-29

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Downtrend (SMA20 < SMA50 < SMA200)

Momentum

Negative momentum · 20D -2.9% · 60D -21.4%

RSI / MACD

RSI 44.9 (Neutral) · MACD hist +0.02

Volatility

Volatility normal (Z -0.49)

SMA20

3.39

SMA50

3.80

SMA200

5.26

EMA12

3.32

EMA26

3.46

BB Upper

3.74

BB Mid

3.39

BB Lower

3.04

RET 5D

+2.8%

RET 20D

-2.9%

RET 60D

-21.4%

RET 120D

-33.2%

As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data